MONITORING IMMUNODYNAMICS IN IMMUNE CHECKPOINT INHIBITOR THERAPY FOR STAGE IIIB/IV NON-SMALL CELL LUNG CANCER

D. Bento (Coimbra, Portugal), J. Almeida (Coimbra, Portugal), P. Couceiro (Coimbra, Portugal), V. Alves (Coimbra, Portugal), M. Santos-Rosa (Coimbra, Portugal), F. Barata (Coimbra, Portugal), P. Rodrigues-Santos (Coimbra, Portugal), A. Ferreira Rodrigues Figueiredo (Coimbra, Portugal)

Source: International Congress 2018 – Lung cancer: personalised medicine
Session: Lung cancer: personalised medicine
Session type: Poster Discussion
Number: 2226
Disease area: Thoracic oncology

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Bento (Coimbra, Portugal), J. Almeida (Coimbra, Portugal), P. Couceiro (Coimbra, Portugal), V. Alves (Coimbra, Portugal), M. Santos-Rosa (Coimbra, Portugal), F. Barata (Coimbra, Portugal), P. Rodrigues-Santos (Coimbra, Portugal), A. Ferreira Rodrigues Figueiredo (Coimbra, Portugal). MONITORING IMMUNODYNAMICS IN IMMUNE CHECKPOINT INHIBITOR THERAPY FOR STAGE IIIB/IV NON-SMALL CELL LUNG CANCER. 2226

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: